Testosterone Replacement Therapy

Have You or a Loved One Suffered a Heart-Attack, Stroke, Clot, or Death While Taking Testosterone Therapy?

Testosterone Therapy Lawsuit Attorneys (AndroGel, Axiron, Testim, Testopel, Bio-T-Gel)

Testosterone replacement therapy drugs like AndroGel have been accused of causing serious health problems.

If you or a loved one were given testosterone therapy and experienced negative side effects such as a heart attack, stroke, or clot, please contact The Cochran Firm, D.C. You may be entitled under the law to compensation. Call 1-800-THE-FIRM to receive a free evaluation. All initial inquiries are confidential and carry no obligation.

Testosterone therapy has become extremely popular in recent years: almost 3% of American men older than 40 have reportedly been prescribed testosterone therapy. Recent medical studies on testosterone replacement therapy have reported heart attacks, clots, strokes, and other cardiovascular problems associated with the medication. Product liability attorneys with The Cochran Firm, D.C. are analyzing potential claims against individuals who were given testosterone therapy drugs. Because deadlines apply to filing a claim seeking compensation, we recommend contacting our team of legal professionals as soon as possible.

We can help with cases related to:

• Androgel
• Axiron
• Androderm
• Bio-T-Gel
• Fortesta
• Striant
• Testim
• Testopel

What have studies found about testosterone therapy and an increased risk of heart attack, stroke, and death?

In 2010, medical researchers halted a large study of testosterone in senior men because patients taking the hormone were five times more likely to suffer a serious heart event, including heart attacks and stroke, than those taking placebos.

A 2013 study published in the Journal of the American Medical Association involved men with low testosterone levels who underwent coronary angiography in the VA system between 2005 and 2011. Testosterone therapy was associated with an increased risk of adverse outcomes compared with those who did not get testosterone therapy.

A 2014 NIH-funded study found that the risk of heart attacks after using testosterone drugs was twice as high in men 65 and older and almost three times as high in men younger than 65 with a history of heart disease.

Health problems associated with “Low T” testosterone replacement therapy may include:

• Stroke
• Heart attack
• Congestive heart failure
• Death

In light of these studies’ findings, the FDA announced on Jan. 31, 2014, that it is investigating the risk of stroke, heart attack, and death in men taking FDA-approved testosterone products.

On Feb. 25, 2014, consumer advocacy organization Public Citizen petitioned the FDA to add a black box warning about the increased risks of heart attacks, stroke, and death to the product labeling of testosterone drugs. Public Citizen also requested that drug makers send “Dear Doctor” letters to physicians to warn them of these adverse effects and to require that the FDA-approved medication guide provided when patients receive prescriptions include this new warning.

“Low T” Testosterone Replacement Therapy

Users take testosterone supplements often because they are advertised to improve mood, and to increase muscle mass, energy, and sex drive. The therapy can be administered by a patch, gel, or injection. Large television campaigns have promoted testosterone replacement therapy as a solution for “low T.” The marketing campaigns have been extremely effective as sales of AndroGel testosterone therapy were higher than Viagra in 2013, according to media reports.

Brands of testosterone replacement drugs include:

• AndroGel – made by AbbVie and Abbot Laboratories
• Axiron – made by Lilly USA
• Androderm – made by Actavis
• Bio-T-Gel – made by Bio Sante Pharmaceuticals and Teva Pharmaceuticals
• Delatestryl – made by Indevus Pharmaceuticals
• Fortesta – made by Endo Pharmaceuticals
• Striant – made by Mipharm S.p.A. and Columbia Laboratories
• Depo–Testosterone – made by Pfizer
• Testim – made by Auxilium Pharmaceuticals and Glaxo Smith Kline
• Testopel – made by Auxilium Pharmaceuticals

What Testosterone Replacement Therapy Lawsuits Have Been Filed?

Lawsuits by men who suffered heart problems after taking Androgel, Axiron, Androderm, and other testosterone replacement therapy drug are filing lawsuits nationwide. The following plaintiffs are not represented by The Cochran Firm, D.C., but are representative of the ongoing litigation regarding testosterone replacement therapy drugs.

• Androderm lawsuit: Smyer and Smyer v. Actavis, et al.: Lawsuit alleges cardiovascular injuries caused by Androderm testosterone patch. The complaint accuses the makers of Androderm of deceptively marketing the low-T product as safe despite knowing of serious health risks.
• Michael Gallagher v. AbbVie Inc. and Abbot Laboratories Inc.: The lawsuit alleges that AbbVie and Abbot Laboratories knew about the dangers of AndroGel before marketing, selling, and distributing the testosterone replacement therapy drug. The complaint alleges that the defendants knew the medication would cause severe physical, mental, and emotional injuries and that the medication presented a “substantial and unreasonable risk of harm to the public.”
• Steven Myers v. AbbVie Inc. and Abbot Laboratories Inc.: The legal claim alleges that consumers of AndroGel were misled about the testosterone drug’s safety and effectiveness and “as a result suffered injuries including life-threatening cardiac events, strokes, and thrombolytic events.”
• Steve Marino v. AbbVie Inc. and Abbot Laboratories Inc.: The testosterone replacement therapy lawsuit alleges that the prescription drug AndroGel is misrepresented as a safe and effective treatment for hypogonadism or “low testosterone,” when the drug causes life-threatening cardiac events, thrombolytic events, and strokes.
• Kenneth Aurecchia v. AbbVie Inc. and Abbot Laboratories Inc.: The testosterone lawsuit avers that the defendants engaged in an aggressive marketing and advertising campaign and an unbranded “disease awareness” campaign to create demand for “low T” testosterone replacement therapy medication. The legal claim alleges that AbbVie and Abbot failed to warn consumers about AndroGel’s risks and negligently caused injuries, harm. The suit also claims that the defendants were fraudulent in concealing from physicians and the general public the dangers associated with the medication.
• Stephen Benn v. AbbVie Inc. and Abbot Laboratories Inc.: The lawsuit alleges that consumers of AndroGel were misled about its safety and effectiveness and that the testosterone drug causes serious medical problems.

How Can I Talk to a Low Testosterone Drug Lawyer?

Experienced product liability attorneys with The Cochran Firm, D.C. are accepting claims on behalf of patients who suffered adverse health effects while on testosterone replacement therapy or “low T” drugs. If you or someone you love took testosterone replacement medication and experienced a negative side effect, please contact our team of legal professionals to receive a free case consultation. All initial inquiries carry no charge or obligation and are confidential.